UAE company nears end of Chinese Covid-19 vaccine trial

article author: 
Thu, 2020-10-08 10:00

ABU DHABI: A United Arab Emirates company is nearing the end of Phase III clinical trials of a Chinese COVID-19 vaccine and hopes to manufacture it next year, a representative said.
The trial, which began in mid-July, is a partnership between Sinopharm’s China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42).
The vaccine uses an inactivated virus; a well-known technology which has been used against diseases such as influenza and measles. Two doses are given.

Main category: 

Leave a Reply

Your email address will not be published. Required fields are marked *